What does Surveyor invest in?
Surveyor invests most often at Series B (100% of the rounds on record).
Filed with the SEC to raise a fund in Sep 2024. Last cheque observed Apr 2019.
QuietNew fund, Sept 2024Private equity
4 rounds on record
Mostly Series B: 100% of its rounds
Every round we can evidence, newest first4 appearances
3 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
The investors most often in the same rounds as Surveyor. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Surveyor put money into.
Surveyor invests most often at Series B (100% of the rounds on record).
4 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2019.
Its most recent investments on record: Sasuma Pharmaceuticals (Undisclosed round, Apr 2019), SpringWorks Therapeutics (Series B, Apr 2019) and Prevail Therapeutics (Series B, Mar 2019).
The median round it joins is $78M.
No investments in the last 12 months; the latest was in Apr 2019.
Most often OrbiMed (3 rounds together), Alexandria Real Estate Equities (2 rounds together) and ArrowMark Partners (2 rounds together).
Surveyor is a private equity firm.
Its latest fund filing with the SEC was in Sept 2024.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it